Vimarsana
Biggest News Aggregation in the World

Planned Separation Remains News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Planned Separation Remains. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Planned Separation Remains Today - Breaking & Trending Today

Alkermes Appoints Caroline J. Loew, Ph.D., as Chief Executive Officer Designate of Mural Oncology plc - Vimarsana News

Alkermes Appoints Caroline J. Loew, Ph.D., as Chief Executive Officer Designate of Mural Oncology plc

Published: June 1, 2023

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that Caroline J. Loew, Ph.D., has been appointed as the chief executive officer designate of Mural...

Source: prnewswire.com
Related Topics:
United KingdomUnited StatesCity OfCarolinej LoewGlympse BioJit BhowmickKatie JoyceCaroline LoewSandy CoombsDrug AdministrationImperial College LondonExchange CommissionAssume New Leadership Role Upon CompletionPlanned SeparationAlkerme Oncology BusinessPlanned Separation RemainsSecond HalfMural OncologyRichard PopsVice PresidentBristol Myers SquibbNorganic ChemistryImperial CollegeUnited States SecuritiesNemvaleukin Alfa
Alkermes plc: Alkermes Appoints Caroline J. Loew, Ph.D., as Chief Executive Officer Designate of Mural Oncology plc - Vimarsana News

Alkermes plc: Alkermes Appoints Caroline J. Loew, Ph.D., as Chief Executive Officer Designate of Mural Oncology plc

Published: June 1, 2023

- Dr. Loew to Assume New Leadership Role Upon Completion of the Planned Separation of Alkermes' Oncology Business - - Planned Separation Remains on Track to be Completed in Second Half

Source: finanznachrichten.de
Related Topics:
City OfUnited KingdomUnited StatesCaroline LoewSandy CoombsCarolinej LoewKatie JoyceJit BhowmickGlympse BioImperial College LondonExchange CommissionDrug AdministrationAssume New Leadership Role Upon CompletionPlanned SeparationAlkerme Oncology BusinessPlanned Separation RemainsSecond HalfMural OncologyRichard PopsVice PresidentBristol Myers SquibbNorganic ChemistryImperial CollegeUnited States SecuritiesNemvaleukin Alfa